Axovant Sciences Ltd (NYSE:AXON) shares are falling nearly 12% following the news that Lundbeck’s experimental Alzheimer’s drug Idalopirdine failed in a late-stage study. …
The biotech sector has had a cruel start to the year. The Nasdaq Biotechnology Index (IBB) is down 23% so far in 2016, …
Cisco Systems (CSCO) stock has been volatile following the last 10 quarterly reports, with an average move of 9%, according to Evercore analysts Mark McKechnie …
